Chad Winters
At a glance: Chad Winters is Vp, Chief Accounting Officer at West Pharmaceutical Services (WST). Their latest SEC Form 4, filed Apr 29, 2026, reported a sale of $269K. On file: 0 purchase lines ($0) and 1 sale line ($269K).
Disclosed holdings: about $594K of WST stock: 1,523 shares reported on their latest Form 4 (filed Apr 29, 2026), valued at the Nov 20, 2026 close of $390.30. This counts only WST shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Vp, Chief Accounting Officer at West Pharmaceutical Services Inc (WST)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 29SEC | WSTWest Pharmaceutical Services Inc | Sell | 8961,523 held (−37%) | $300.67 | $269K | +29.8% |
- Sell
Vp, Chief Accounting Officer Chad Winters sold $269K of WST at $300.67 — cuts the stake by 37%.
Follow Chad Winters
Get one email when Chad Winters files a new purchase or sale. Free.
At most one email a day about Chad Winters, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.